Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.26K Sell
9
-1
-10% -$342 0.08% 135
2026
Q1
$3.49K Sell
10
-2
-17% -$713 0.12% 132
2025
Q4
$3.93K Buy
12
+3
+33% +$952 0.12% 136
2025
Q3
$2.64K Hold
9
0.1% 145
2025
Q2
$2.51K Hold
9
0.12% 124
2025
Q1
$2.83K Sell
9
-4
-31% -$1.18K 0.16% 122
2024
Q4
$3.39K Sell
13
-1
-7% -$297 0.15% 121
2024
Q3
$4.51K Buy
14
+6
+75% +$1.96K 0.4% 54
2024
Q2
$2.5K Sell
8
-4
-33% -$1.18K 0.21% 117
2024
Q1
$3.41K Buy
12
+1
+9% +$293 0.17% 121
2023
Q4
$3.31K Buy
11
+2
+22% +$545 0.16% 144
2023
Q3
$734 Sell
9
-3
-25% -$749 0.03% 179
2023
Q2
$2.66K Sell
12
-3
-20% -$696 0.16% 99
2023
Q1
$3.63K Sell
15
-11
-42% -$2.7K 0.24% 95
2022
Q4
$6.83K Buy
+26
New +$6.97K 0.46% 58

Other funds holding AMGN

PayPay Securities's AMGN Position: Q2 2026 in Review

PayPay Securities reduced its Amgen (AMGN) stake by 10% in Q2 2026, selling an estimated $342 and leaving 9 shares worth $3.26K. The position accounts for 0.08% of the portfolio, ranked #135.

PayPay Securities first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $6.83K in Q4 2022. 1,227 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • PayPay Securities held 9 shares of Amgen worth $3.26K as of Q2 2026.
  • PayPay Securities sold 1 Amgen share in Q2 2026, an estimated $342.
  • Amgen made up 0.08% of PayPay Securities's portfolio in Q2 2026, its #135 holding.
  • PayPay Securities first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • PayPay Securities's Amgen position peaked at $6.83K in Q4 2022.
  • 1,227 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on PayPay Securities's 13F filing for Q2 2026, filed 23 Jul 2026.